AGMB-129 hit all primary and secondary endpoints in interim read-out from 44 patients after 12 weeks treatment -- ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible resultsSome results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback